Page 121 - 2020年21期
P. 121
validation of the revised patients’attitudes towards depre- 173-184.
scribing（rPATD）questionnaire：versions for older adults [25] 石力文，周俊，毛宗福，等.基于 CiteSpace 的全球健康热
and caregivers[J]. Drugs Aging，2016，33（12）：913-928. 点与前沿分析[J].现代预防医学，2019，46（10）：1801-
[17] REEVE E，WOLFF JL，SKEHAN M，et al. Assessment of 1805、1810.
attitudes toward deprescribing in older medicare beneficia- [26] KHEZRIAN M，MCNEIL CJ，MURRAY AD，et al. An
ries in the United States[J]. JAMA Intern Med，2018，178 overview of prevalence，determinants and health out-
（12）：1673-1680. comes of polypharmacy[J]. Ther Adv Drug Saf，2020.
[18] JOKANOVIC N，TAN EC，DOOLEY MJ，et al. Preva- DOI：10.1177/2042098620933741.
lence and factors associated with polypharmacy in [27] WALCKIERS D，VAN DER HEYDEN J，TAFFOREAU
long-term care facilities：a systematic review[J]. J Am J. Factors associated with excessive polypharmacy in ol-
Med Dir Assoc，2015，16（6）：e1-e12. der people[J]. Arch of Public Health，2015. DOI：10.1186/
[19] GNJIDIC D，HILMER SN，BLYTH FM，et al. High-risk s13690-015-0095-7.
prescribing and incidence of frailty among older communi- [28] JYRKKA J，ENLUND H，KORHONEN MJ，et al. Pat-
ty-dwelling men[J]. Clin Pharmacol Ther，2012，91（3）： terns of drug use and factors associated with polypharma-
521-528. cy and excessive polypharmacy in elderly persons results
[20] HUBBARD RE，O’MAHONY MS，WOODHOUSE KW. of the Kuopio 75 + study：a cross-sectional analysis[J].
Medication prescribing in frail older people[J]. Eur J Clin Drugs Aging，2009，26（6）：493-503.
Pharmacol，2013，69（3）：319-326. [29] JUNIUS-WALKER U，THEILE G，HUMMERS-PRADI-
[21] GNJIDIC D，HILMER SN，BLYTH FM，et al. Polyphar- ER E. Prevalence and predictors of polypharmacy among
macy cutoff and outcomes：five or more medicines were older primary care patients in Germany[J]. Fam Pract，
used to identify community-dwelling older men at risk of 2007，24（1）：14-19.
different adverse outcomes[J]. J Clin Epidemiol，2012，65 [30] CASHION W，MCCLELLAN W，HOWARD G，et al.
（9）：989-995. Geographic region and racial variations in polypharmacy
[22] SCOTT IA，HILMER SN，REEVE E，et al. Reducing inap- in the United States[J]. Ann Epidemiol，2015，25（6）：
propriate polypharmacy the process of deprescribing[J]. 433-438.
JAMA Internal Medicine，2015，175（5）：827-834. [31] PATTERSON SM，HUGHES C，KERSE N，et al. Interven-
[23] RADCLIFF S，YUE JR，ROCCO G，et al. American Ge- tions to improve the appropriate use of polypharmacy for
riatrics Society 2015 updated Beers criteria for potentially older people[J]. Cochrane Database Syst Rev，2012. DOI：
inappropriate medication use in older adults[J]. J Am Ge- 10.1002/14651858.CD008165.pub4.
riatr Soc，2015，63（11）：2227-2246. [32] 赵丽艳，赵忠鹏，程艳芹，等.老年人不适当用药的研究进
[24] SPINEWINE A，SCHMADER KE，BARBER N，et al. Ap- 展[J].中国医药导报，2019，16（21）：47-50.
propriate prescribing in elderly people：how well can it be （收稿日期：2020-07-17 修回日期：2020-08-17）
measured and optimised?[J]. Lancet，2007，370（9582）： （编辑：刘明伟）
《中国药房》杂志——中国科技核心期刊，欢迎投稿、订阅
中国药房 2020年第31卷第21期 China Pharmacy 2020 Vol. 31 No. 21 ·2671 ·
